
Shutterstock
Pennsylvanians with asthma are seeing the price of their inhalers drop from $645 to $35, thanks to the Inflation Reduction Act.
Here’s who’s paying less for asthma inhalers, and why:
Who: In Pennsylvania, more than 1 million adults and 9% of kids suffer from asthma, according to the Centers for Disease Control and Prevention and the United Health Foundation.
What they’re saving on: Inhalers, which—until now—have been significantly overpriced in the US compared to other countries.
An investigation by the Democratic-led Senate Committee on Health, Education, Labor and Pensions noted that before the new price cap, drugmaker AstraZeneca charged $645 in the US for the same inhaler it charged $49 for in the United Kingdom.
What they cost now: Inhalers from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline have been capped to $35 a month.
The cost cap went into effect for AstraZeneca and Boehringer Ingelheim at the beginning of June. GlaxoSmithKline’s cap is expected to take effect by Jan. 1, 2025.
For AstraZeneca inhalers, both privately insured and uninsured patients will be eligible for the price cap.
For Boehringer Ingelheim inhalers, the $35 cap will be automatically applied at the pharmacy for the majority of patients with commercial insurance. Those without insurance can visit the company’s website where they can enroll for a copay card that will reduce the out-of-pocket cost to $35.
The price cap on GlaxoSmithKline inhalers will be available to all patients, regardless of insurance status.
What’s behind the price reduction?
The Inflation Reduction Act was largely touted as a win for climate change and clean
energy when President Joe Biden signed it into law in 2022. But it also included health care provisions that capped the cost of certain prescriptions for items such as insulin and inhalers.
Support Our Cause
Thank you for taking the time to read our work. Before you go, we hope you'll consider supporting our values-driven journalism, which has always strived to make clear what's really at stake for Pennsylvanians and our future.
Since day one, our goal here at The Keystone has always been to empower people across the commonwealth with fact-based news and information. We believe that when people are armed with knowledge about what's happening in their local, state, and federal governments—including who is working on their behalf and who is actively trying to block efforts aimed at improving the daily lives of Pennsylvania families—they will be inspired to become civically engaged.


Two hospitals to close after Pa. officials provided $40 million to help company find a buyer
Prospect Medical Holdings, which filed for bankruptcy in January, will shutter pair of Delaware County facilities. A California for-profit health...

Opinion: I’m chronically ill, but can hold a job at Sheetz thanks to Medicaid. Cuts would put me at risk.
Beaver resident Carly Morton writes about how she relies on Medicaid to survive and work, and highlights the potentially devastating consequences of...

Deal struck to keep Pa. hospital system open – for now
If a pair of its hospitals close, the state’s fifth most populous county would only have two left. An agreement has been made to keep a pair of...

One of Pa.’s most populated counties could be down to two hospitals soon
Reports surfaced Thursday that a Delaware County hospital system could close two hospitals. Prospect Medical Holdings Inc. might close two hospitals...

PA medicaid abortion exclusion deemed “presumptively unconstitutional”
Though access to abortion is still legal in Pennsylvania, it is highly restricted for Medicaid recipients, prompting several reproductive healthcare...